United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - eprosartan mesylate (unii: 8n2l1nx8s3) (eprosartan - unii:2kh13z0s0y) - eprosartan 600 mg - eprosartan mesylate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensives such as diuretics and calcium channel blockers. eprosartan mesylate tablets are contraindicated in patients who are hypersensitive to this product or any of its components. do not co-administer aliskiren with eprosartan in patients with diabetes (see precautions: drug interactions).

Ireland - English - HPRA (Health Products Regulatory Authority)

niche generics limited - eprosartan mesylate - film coated tablet - 300 milligram - eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

niche generics limited - eprosartan mesylate - film coated tablet - 400 milligram - eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

niche generics limited - eprosartan mesylate - film coated tablet - 600 milligram - eprosartan - angiotensin ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - eprosartan mesylate (unii: 8n2l1nx8s3) (eprosartan - unii:2kh13z0s0y), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - eprosartan 600 mg - teveten® hct is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensives such as calcium channel blockers. this fixed dose combination is not indicated for initial therapy (see dosage and administration ). teveten® hct is contraindicated in patients who are hypersensitive to this product or any of its components. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - eprosartan mesylate - film-coated tablet - 300 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - eprosartan mesylate - film-coated tablet - 400 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - eprosartan mesylate - film-coated tablet - 600 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - eprosartan mesylate - film coated tablet - 400 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - eprosartan mesylate - film coated tablet - 600 milligram